期刊文献+

胶带粘贴技术结合LC-MS法测定人体皮肤角质层中艾迪康唑浓度 被引量:5

Tape stripping technique in combination with LC-MS method for the determination of iodiconazole in human stratum corneum
下载PDF
导出
摘要 采用胶带粘贴技术采集人体浅层皮肤样本,经提取处理后进行LC-MS测定,建立了人体皮肤角质层中艾迪康唑的定量分析方法。LC-MS测定以酮康唑为内标,甲醇-0.01%甲酸水溶液(65∶35)为流动相,经Shim-pack VP ODS C18 柱分离后,电喷雾离子化,选择性正离子检测。研究表明该方法在0.6~1 800 ng/mL范围内线性关系良好(r=0.999 8),方法回收率、批内及批间精密度均符合生物样本药物浓度测定要求。运用该方法对10例健康志愿者外用艾迪康唑乳膏后皮内药物浓度的动态变化过程进行了初步考察,结果表明该方法灵敏、专属,可用于人体局部外用艾迪康唑乳膏后角质层中药物浓度测定及人体皮肤药代动力学研究。 A quantitative analysis method of iodiconazole concentrations in human stratum corneum was established. Human superficial skin samples were obtained by tape stripping technique and iodiconazole concentrations were determined by LC-MS method after extraction. Ketoconazole was used as the internal standard(IS). The analytes were chromatographically separated on a Shim-pack VP-ODS C18 column with the mobile phase consisting of methanol and 0. 01% formic acid aqueous solution(65 ∶35). Mass spectrometer was operated in positive ion and selective ion monitoring(SIM)mode using electrospray ionization(ESI)technique. The method showed excellent linearity over the concentration range of 0. 6-1 800 ng/mL. The recovery and the intra- and inter-batch precisions met the requirements for the determination of biological samples. The dynamic process of intradermal drug concentrations in 10 healthy volunteers after topical application of iodiconazole cream was investigated using this method. The method proved to be selective and sensitive, and suitable for the determination of iodiconazole concentration in human stratum corneum and the pharmacokinetic study after topical application of iodiconazole cream.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2014年第1期79-83,共5页 Journal of China Pharmaceutical University
关键词 艾迪康唑 皮肤药代动力学 LC-MS 胶带粘贴 角质层 含量测定 iodiconazole dermatopharmacokinetic LC-MS tape stripping stratum corneum determination
  • 相关文献

参考文献2

二级参考文献26

  • 1Yotsuji A,Shimizu K,Araki H,et al.T-8581,a new orally and parenterally active triazole antifungal agent:in vitro and in vivo evaluations[J].Antimicrob Agents Chemother,1997,41(1)∶30-34.
  • 2Ji HT,Zhang WW,Zhou YJ,et al.A three-dimensional model of lanosterol 14α-demethylase of Candida albicans and its interaction with azole antifungals[J].J Med Chem,2000,43(13)∶2493-2505.
  • 3Robert A,Fromtling J,Castaner L.Syn-2869[J].Drugs Fut,1999,24(1)∶30-37.
  • 4Ji HT,Zhang WN,Zhang M,et al.Structure-based de novo design,synthesis,and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi[J].J Med Chem,2003,46(4)∶474-485.
  • 5Pfaller MA,Messer SA,Hollis RJ,et al.In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147,Sch 56592,and voriconazole[J].Antimicrob Agents Chemother,1998,42(12)∶3242-3244.
  • 6Law D,Moore CB,Denning DW.Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp[J].Antimicrob Agents Chemother,1997,41(10)∶2310-2311.
  • 7Fung-Tomc JC,Huczko E,Minassian B,et al.In vitro activity of a new oral triazole,BMS-207147 (ER-30346)[J].Antimicrob Agents Chemother,1998,42(2)∶313-318.
  • 8Schell WA,De Almeida GM,Dodge RK,et al.In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformans[J].Antimicrob Agents Chemother,1998,42(10)∶2630-2632.
  • 9Surber C,Schwarb FP,Smith EW.Tape-stripping technique[A].Bronaugh RL,Maibach HI.Percutaneous Absorption.Drugs-Cosmetics-Mechanisms-Methodology[M].Boca Raton:Taylor and Francis,2005:399-410.
  • 10Jacobi U,Weigmann H-J,Ulrich J,et al.Estimation of the relative stratum corneum amount removed by tape stripping[J].Skin Res Technol,2005;11:91-96.

共引文献20

同被引文献38

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部